Codexis Inc (CDXS)

$2.11 -0.18 (-7.86%)
Market Cap 207.92M
Revenue (ttm) 59.35M
Net Income (ttm) -65.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -109.99%
Debt to Equity Ratio 0.43
Volume 921,258
Avg Vol 940,114
Day's Range N/A - N/A
Shares Out 82.84M
Stochastic %K 7%
Beta 2.34
Analysts Strong Sell
Price Target $7.00

Latest News on CDXS

Codexis Announces New Employment Inducement Grants

Mar 7, 2025, 4:05 PM EST - 27 days ago

Codexis Announces New Employment Inducement Grants

Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:20 PM EST - 5 weeks ago

Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Feb 13, 2025, 4:05 PM EST - 7 weeks ago

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

Feb 6, 2025, 4:05 PM EST - 2 months ago

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

Codexis Appoints Christos Richards to Board of Directors

Jan 16, 2025, 4:05 PM EST - 2 months ago

Codexis Appoints Christos Richards to Board of Directors

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 4:05 PM EST - 4 months ago

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Nov 14, 2024, 4:05 PM EST - 5 months ago

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

Nov 12, 2024, 4:05 PM EST - 5 months ago

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Nov 11, 2024, 4:05 PM EST - 5 months ago

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Codexis to Participate in Upcoming Healthcare Conferences

Nov 4, 2024, 4:05 PM EST - 5 months ago

Codexis to Participate in Upcoming Healthcare Conferences

Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 10:48 PM EDT - 5 months ago

Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

Oct 24, 2024, 4:05 PM EDT - 5 months ago

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

Codexis to Report Third Quarter 2024 Financial Results on October 31

Oct 10, 2024, 4:05 PM EDT - 6 months ago

Codexis to Report Third Quarter 2024 Financial Results on October 31

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Oct 2, 2024, 4:05 PM EDT - 6 months ago

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

Oct 1, 2024, 7:05 AM EDT - 6 months ago

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

Aug 20, 2024, 4:05 PM EDT - 8 months ago

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

Codexis Publishes FY2023 Sustainability Disclosures

Aug 15, 2024, 4:05 PM EDT - 8 months ago

Codexis Publishes FY2023 Sustainability Disclosures

Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 11:01 PM EDT - 8 months ago

Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript

Codexis to Report Second Quarter 2024 Financial Results on August 8

Jul 18, 2024, 4:05 PM EDT - 9 months ago

Codexis to Report Second Quarter 2024 Financial Results on August 8

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

Jul 1, 2024, 4:05 PM EDT - 9 months ago

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

Codexis to Participate in Jefferies Global Healthcare Conference

May 22, 2024, 4:25 PM EDT - 11 months ago

Codexis to Participate in Jefferies Global Healthcare Conference

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

May 20, 2024, 4:05 PM EDT - 11 months ago

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

May 14, 2024, 6:00 AM EDT - 11 months ago

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript

May 2, 2024, 8:24 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript

Codexis to Report First Quarter 2024 Financial Results on May 2

Apr 18, 2024, 4:05 PM EDT - 1 year ago

Codexis to Report First Quarter 2024 Financial Results on May 2

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Apr 11, 2024, 7:05 AM EDT - 1 year ago

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 10:39 PM EST - 1 year ago

Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 28, 2024, 4:05 PM EST - 1 year ago

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

Feb 26, 2024, 4:05 PM EST - 1 year ago

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

Feb 26, 2024, 8:05 AM EST - 1 year ago

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Feb 20, 2024, 8:05 AM EST - 1 year ago

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Feb 14, 2024, 4:05 PM EST - 1 year ago

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

Feb 13, 2024, 4:05 PM EST - 1 year ago

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

Feb 1, 2024, 4:05 PM EST - 1 year ago

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Dec 27, 2023, 8:30 AM EST - 1 year ago

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Dec 13, 2023, 4:06 PM EST - 1 year ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Dec 13, 2023, 4:05 PM EST - 1 year ago

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

Dec 11, 2023, 7:05 AM EST - 1 year ago

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

Nov 28, 2023, 4:05 PM EST - 1 year ago

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

Nov 14, 2023, 4:05 PM EST - 1 year ago

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 9:32 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

Codexis Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Codexis Reports Third Quarter 2023 Financial Results

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

Oct 27, 2023, 3:35 PM EDT - 1 year ago

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

Codexis to Report Third Quarter 2023 Financial Results on November 2

Oct 19, 2023, 4:05 PM EDT - 1 year ago

Codexis to Report Third Quarter 2023 Financial Results on November 2

Checking Out Codexis

Oct 5, 2023, 2:11 PM EDT - 1 year ago

Checking Out Codexis

Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

Sep 29, 2023, 7:05 AM EDT - 1 year ago

Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

Sep 18, 2023, 4:05 PM EDT - 1 year ago

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

Codexis to Participate in Cantor Global Healthcare Conference

Sep 12, 2023, 4:05 PM EDT - 1 year ago

Codexis to Participate in Cantor Global Healthcare Conference

Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease

Sep 7, 2023, 4:05 PM EDT - 1 year ago

Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease

Codexis Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 4:05 PM EDT - 1 year ago

Codexis Reports Second Quarter 2023 Financial Results